ArticleBMJ open2024

Efficacy and safety of deferoxamine, deferasirox and deferiprone triple iron chelator combination therapy for transfusion-dependent β-thalassaemia with very high iron overload: a protocol for randomised controlled clinical trial.

Anuja Premawardhena et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.